Real-Time Dynamic Imaging of Virus Distribution In Vivo by Hofherr, Sean E. et al.
Real-Time Dynamic Imaging of Virus Distribution In Vivo
Sean E. Hofherr
1., Kristen E. Adams
4., Christopher Y. Chen
2, Shannon May
2, Eric A. Weaver
2, Michael A.
Barry
2,3*
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America, 2Department of Internal Medicine, Translational
Immunovirology and Biodefense Program, Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America, 3Department of Immunology,
Department of Molecular Medicine, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, United States of America, 4Institute for Molecular Medicine, University of
Texas Health Science Center, Houston, Texas, United States of America
Abstract
The distribution of viruses and gene therapy vectors is difficult to assess in a living organism. For instance, trafficking in
murine models can usually only be assessed after sacrificing the animal for tissue sectioning or extraction. These assays are
laborious requiring whole animal sectioning to ascertain tissue localization. They also obviate the ability to perform
longitudinal or kinetic studies in one animal. To track viruses after systemic infection, we have labeled adenoviruses with a
near-infrared (NIR) fluorophore and imaged these after intravenous injection in mice. Imaging was able to track and
quantitate virus particles entering the jugular vein simultaneous with injection, appearing in the heart within 500
milliseconds, distributing in the bloodstream and throughout the animal within 7 seconds, and that the bulk of virus
distribution was essentially complete within 3 minutes. These data provide the first in vivo real-time tracking of the rapid
initial events of systemic virus infection.
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Introduction
The fields of gene therapy, virology, cell and molecular biology,
and others have all benefited from the use of reporter genes that
allow the tracking of protein expression both in vitro and in vivo. For
instance, reporter transgene expression has been used to track viral
infection and spread in laboratory animals [1,2,3]. However,
many next-generation viral and non-viral therapies will require
systemic delivery [4]. Vascular administration of a virus or vector
is inefficient in that a significant proportion of virus infects non-
target tissues or is consumed by immune cells (reviewed in [5]). It is
critical to understand where and how fast vector particles are
being sequestered or conversely how long they are staying in
circulation.
Reporter proteins are typically fluorescent proteins or lumines-
cent proteins. Fluorescent proteins, such as GFP, DsRed, CFP,
and others emit light when excited by a specific wavelength of
light. Chemiluminescent reporters like luciferase, catalyze the
reaction on a substrate often supplied in trans leading to photon
release. Reporter genes have also been inserted into the genomes
of viruses to track infection patterns and tropism. In vivo detection
of these reporter proteins relies on imaging with sensitive charge-
coupled device (CCD) cameras which have been integrated into
complete whole-animal imaging systems. The evolution of imaging
technology combined with the identification of improved reporter
proteins has allowed researchers to effectively track viral transgene
expression in vivo, but has a limited capacity to provide information
about early kinetics and tropism of viral vectors.
A major limitation of using reporter genes for viral vector
tracking and tropism is that only those viruses or vectors that are
successful are tracked. That is, only vectors that succeed in cell
entry and genome delivery generate a signal. In contrast, all failed
or lost virions are undetected. Since the vast majority of virus
particles are likely to be adsorbed without productive infection of
cells, reporter gene imaging gives a skewed report of virus or
vector distribution that may mislead interpretation of the
pharmacology of these agents. In addition, the time necessary
for the reporter transgene to be expressed in detectable quantities
can be anywhere from hours to days post-injection, at which time,
most vector trafficking has already occurred.
An alternate method for observing virion kinetics would be to
label the particles with a molecule suitable for imaging.
Fluorescent molecules that have been either chemically coupled
to or genetically engineered into the viral capsid are an obvious
candidate. Unfortunately, animal tissues have very high autofluo-
rescence in the UV and visible light ranges making it difficult to
resolve signal from noise using popular fluorophores or fluorescent
proteins. Since there is little biological autofluorescence in the
near-infrared infrared spectrum, new near-infrared fluorescent
proteins are being developed. However, these are not sufficiently
sensitive to track virions rather than transgenes in vivo.
In this work, we have conjugated the near-infrared (NIR) small
molecule fluorophore IR800 to adenovirus (Ad) to track its rapid and
realtime distribution in vivo in mice. We demonstrate this method can
track virus distribution within seconds of injection and can be used to
monitor the effects of engineering to modify virus tropism.
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Virus Preparations
All viruses were grown, purified, and stored in 0.5 M KPBS
buffer as previously described [6]. Ad-GL is a first generation
version of adenovirus serotype 5 (Ad5) containing GFP-Luciferase
fusion protein as a transgene under the control of the
cytomegalovirus (CMV) promoter.
Virus Labeling
IR800-CW was purchased from Licor Biotechnology (Lincoln,
Nebraska USA). The dye was reconstituted according to
manufacturer’s directions in anhydrous dimethyl-sulfoxide
(DMSO from Sigma) at a concentration of 5 mg/100 mL. The
replication defective Ad5 (Ad-GL) was labeled at two different
concentrations (high-dye and low-dye). The high-dye Ad-GL
conjugation used 100,000 dye molecules/viral particle and the
low-dye Ad-GL was labeled at a concentration of 10,000 dye
molecules/viral particle. The labeling reaction was carried out for
one hour at room temperature. Tris buffer was added to a final
concentration of 50 mM to inactivate the remaining dye. Excess
unbound free dye was removed by two consecutive size-exclusion
columns (Bio-Rad DG). To determine the effectiveness of the free
dye removal strategy, pure dye was treated with 50 mM Tris
buffer to inactivate all NHS groups and then filtered through two
size exclusion columns. The eluate was imaged with the purified
high-dye and low-dye labeled virus and compared to a standard
curve of dye that had been serially diluted. The mock treated Ad-
GL was prepared under the same conditions as the labeled virus
but in the absence of dye. The final concentration of each virus
was determined by absorbance at 260 nm, and unless otherwise
stated was 1610
12 viral particles/ml. Each mouse was injected
with 200 ml of sample.
Mice
All animal work was conducted after institutional approval by
the Mayo Clinic IACUC, approval number A10109, Animal
Welfare Assurance number A329101. Mice were 6–8 week old
female Crl:SKHI-hr (outbred) and were purchased from Charles
River. Because tail vein injection outside of the imaging system
prevented imaging directly during injection, some experiments
used mice bearing jugular vein catheters (JVC) surgically
implanted by Charles River prior to shipment. This allowed virus
to be injected directly into the mice already in the imaging box
and enabled imaging to commence simultaneous with the
injection. The catheter is a silicone catheter with a length of 82–
88 mm and has a void volume is 10–12 ml. The tip of the catheter
is placed in the right atrium. Once received, the mice were
quarantined for 72 hours prior use. Mice were also ordered with a
vascular access penny (VAP) port (Access Technologies Skokie, IL
USA) implanted by Charles River prior to shipment. The VAP has
a silicone port body with a length of 0.625 inches and a height of
0.25 inches and was directly tied into the right atrium of the
animals.
Realtime NIR imaging of labeled virus
Catheterized mice were anesthetized by intraperitoneal injec-
tion of 100 ml ketamine/xylazine (ketamine: 27.77 mg/ml;
xylazine: 1.11 mg/ml), placed into the imaging box, then injected
via their catheter with 200 ml of tris buffer containing 2610
11 Ad-
GL particles labeled under high- or low-dye conditions. An
additional mouse was injected with 200 ml of dye in Tris buffer
with fluorescence that was equivalent to that of the high-dye Ad.
For movie collection, one mouse was imaged for each condition
using the catheterized mice. Injections in catheterized mice were
validated by injections of a higher number of 5 mice per group by
tail vein for the single 24 hour time point.
During and after these injections, near-IR images were taken
using a Photometrics (Tucson, AZ USA) Lumazone Imager.
Exposures were 250 milliseconds for a single image. Where movies
were assembled, each image was taken every 500 milliseconds for
30 minutes. Images were processed using the Lumazone Imaging
Software. The various time points of the realtime videos were
captured using Hyperionics (Murrysville, PA USA) Hypersnap 6.0.
Quantitation of Regions of Interest
Liver signal was quantified by generating an elliptical region of
interest (ROI 1) in the location of the liver. This ellipse (ROI 1)
was a fixed size for all images. The mean light intensity was
calculated for ROI 1 at each time point using the Lumazone
Imaging Software. Due to slight positioning differences between
mice in the imager the ellipse was centered in the liver area for
each mouse (intermouse experiment), but the location was fixed
for each time-point (intramouse experiment). To control for
background, the mean intensity was calculated by the Lumazone
Imaging Software by generating a small square region of interest
(ROI 2) in the region of the hind limb of the mouse. Similar to the
liver quantitation, ROI 2 was a fixed size for all images, for
intermouse experiments ROI 2 was repositioned and centered in
the hind limb due to positioning differences between mice, and for
intramouse experiments ROI 2 was in a fixed position.
Assessing viral activity following IR-800 labeling
Non-catheterized mice were anesthetized with ketamine/
xylazine (see above) then injected via the tail vein with 200 mlo f
tris buffer containing 2610
11 viral particles of Ad-GL labeled
under high- or low-dye conditions. Control mice were injected
with the same amount of non-labeled Ad-GL. The following day,
these mice were anesthetized and then injected intraperitoneally
with 100 mlo fD-luciferin (20 mg/ml in PBS) and imaged for
luciferase expression. Exposures were one minute in length and
processed without binning. Images were processed using the
Lumazone software for pseudocoloring the differing light inten-
sities. Light intensity was quantitated by summing the detected
lumens within a rectangular region of interest encompassing the
entire animal. After imaging, the mice were euthanized and
necropsied. Livers, spleens, and kidneys were isolated and imaged
for near-infrared fluorescence as described above. N=5.
Results
Adenovirus serotype 5 (Ad5) vector expressing the reporter
GFP-Luc (Ad-GL) was labeled at varied ratios with the amine-
reactive NIR fluorophore IR800. IR800 was selected as the probe,
since its excitation/emission at 745/795 nm provides better signal
to noise than green or far-red fluorophores [7]. 5610
12 Ad-GL
virus particles (vp) were reacted with IR800-CW dye at two ratios;
10,000 dye molecules/virion (low-dye) and 100,000 dye mole-
cules/virion (high-dye). Excess dye was removed using two
6,000 kDa size exclusion chromatography columns. As a negative
control, the same size exclusion protocol was performed on dye
only, resulting in an eluate with no detectable fluorescence. 10
11
vp of the IR800-labeled viruses were imaged on a Lumazone
imaging system. 10
11 vp (1.66610
213 moles) of Ad labeled under
low and high conjugation conditions had equivalent fluorescence
to 10 and 100 picomoles (10
211 and 10
210 moles) of IR800.
Labeling with lower ratios of IR800 produced virions below the
limits of detection for the Lumazone system.
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imaging to occur essentially simultaneously with injection. Mice
were injected with 2610
11 vp the IR800 labeled Ad-GL. For the
low and high virus samples, this equated to injections of 20 and
200 picomoles of fluorophore per mouse. Dye control mice were
injected with 200 picomoles of IR800, equal to the in vitro
fluorescence of the high virus samples. The mice were imaged with
the Lumazone in real time with 250 millisecond image captures
taken every 500 milliseconds (see Figures 1, 2, and 3 for still
individual images and see Supplemental Movies S1, S2 and S3 for
realtime dynamic imaging).
Injection of free IR800 dye produced rapid distribution of the
probe throughout the mouse within seconds of injection and this
systemic fluorescence persisted through the end of the imaging
time course. Although the entire mouse fluoresced, the most
intense region of signal was in the bladder area (Figure 1 and
Supplemental Movie S1). When either of the Ad samples (Ad-GL
labeled with the low and high concentrations of IR800) were
injected, a distinctly different distribution pattern was observed
with highest signals from the virus labeled under the high
conditions (Figure 2 and 3 and Supplemental Movies S2 and
S3). Neither labeled virus sample (low nor high) demonstrated
diffuse spreading through the injected animals, ultimately the
signal localized predominantly to the liver.
When images are analyzed more closely at each time point
(Figure 4) and fluorescence distribution is quantitated (Figure 5),
one can appreciate the rapid biodistribution of Ad virions after i.v.
injection. At injection, background NIR fluorescence is observed
only in the intestinal area due to autofluorescence of chlorophyll in
the mouse chow. At injection, NIR fluorescence is observed
entering the jugular. Within 500 milliseconds virus is detected in
the heart. Within 7 seconds fluorescence is observed throughout
the mouse with reduced signal in the liver due to its size and higher
light absorbance. By 11.25 seconds, NIR fluorescence increases in
the liver and can also be observed in the vasculature of the mice.
Liver NIR signal increased at the expense of fluorescence
elsewhere in the mice. This kinetic of signal loss is consistent with
previous data studying the pharmacology of i.v. injected
radiolabeled Ad5 [8]. By 187.5 seconds (3 minutes), liver NIR
signal appears saturated for the high labeled Ad-GL group with
slight reduction over 750 seconds (12 minutes) of imaging. Ad
labeled at the lower level also accumulated in the liver, but with
slower kinetics. This predominant liver signal is consistent with
previous qPCR data demonstrating that approximately 95 to 99%
of injected Ad5 is found in the liver within 30 minutes of injection
[8].
Quantitation of NIR fluorescence in the liver and hind leg
regions demonstrated distinctly different pharmacokinetics for free
dye vs. labeled Ad (Figure 5). Free dye distributed rapidly to liver
and leg with gradual loss in the liver and gradual increase in the
leg. In contrast, liver signal for the IR800 labeled Ad-GL increased
over time and leg signal was weak peaking at 7.5 seconds and then
reducing to background. By 750 seconds, the NIR fluorescence
ratio of liver:leg for free IR800 was 0.86 whereas this ratio was
3.08 and 1.59 for high and low labeled Ad-GL, respectively. This
liver signal associated with IR800-labeled Ad-GL is consistent with
previous work by tissue sectioning, enzyme assay, and reporter
gene imaging that demonstrates that the liver is the predominant
site of transduction by Ad5 after i.v. injection. Therefore, IR800
imaging of Ad5 virions grossly recapitulates the known tropism of
this virus.
To determine the effect of labeling Ad5 with the 1.1 kDa IR800
molecule, groups of 5 hairless mice were injected i.v. by tail vein
with the high-dye and low-dye labeled Ad-GL as well as a
unlabeled Ad-GL. After 24 hours, luciferase transgene expression
from the virus was measured by imaging to determine the effect of
the labeling on virus activity (Figure 6A and B). Luciferase
expression of the unlabeled Ad-GL injected mice was strong and
restricted to the liver as expected from previous studies. Luciferase
expression from the low-dye labeled Ad-GL injected mice was also
seen in the liver, although the signal was ten-fold lower than
unlabeled Ad-GL. In contrast, the high-dye labeled Ad-GL
injected mice had detectable, but markedly lower luciferase
expression.
Figure 1. NIR imaging of IR800 free dye. Selected frames from a real-time image series taken of a catheterized mouse injected with near-infrared
dye. Dark spot in the neck is from the catheter. Numbers indicate the time post-injection in seconds that the image was taken. ‘‘L’’ indicates the liver
region (see also Figures 2 and 3 for liver localization of Ad-IR800). ‘‘b’’ indicates the bladder region where IR800 dye is eliminated from the body [7].
doi:10.1371/journal.pone.0017076.g001
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(Figure 7). The livers and spleens of the high-dye labeled Ad-GL
injected mice were all fluorescent. Three of five livers of the mice
injected with the low-dye labeled Ad-GL had detectable fluores-
cence, but the intensity in this group was significantly lower than
that of the high-dye group. None of the spleens from mice in the
low-dye Ad-GL had overt fluorescence by imaging. No fluorescence
wasdetected intheorgansfrom theunlabeledAd-GLinjected mice.
Organs were also analyzed by quantitative PCR (qPCR) to
measure the number of adenovirus genomes that were delivered
(Fig. 6C and D). qPCR for unmodified Ad demonstrated highest
viral genome load in the liver with similar lower levels in the kidney
andspleen.Thelowand high-dyelabeledgroupsshowedreductions
in Ad genomes in the liver that paralleled changes in luciferase
activity with the low group having a modest reduction and the high
group reduced 1000-fold. In the spleen, Ad genome levels were
affected more modestly by IR800 modification of the virus. In the
kidney, both labeled groups reduce viral genomes to similar levels.
These data indicated that the heavy dye labeling that best detects
NIR fluorescence in vivo reduced, but did not ablate virus
Figure 2. NIR imaging of Ad labeled with low IR800. Selected frames from a real-time image series taken of a catheterized mouse injected with
Ad5 labeled with the low-dose of near-infrared dye. Dark spot in the neck is from the catheter. Numbers indicate the time in seconds post-injection
that the image was taken.
doi:10.1371/journal.pone.0017076.g002
Figure 3. NIR imaging of Ad labeled with high IR800. Selected frames from a real-time image series taken of a catheterized mouse injected
with Ad5 labeled with the high-dose of near-infrared dye. Dark spot in the neck is from the catheter. Numbers indicate the time in seconds post-
injection that the image was taken.
doi:10.1371/journal.pone.0017076.g003
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relative distribution, the spleen and kidney qPCR values were
divided by those in the liver (Fig. 6D). This comparison indicated
that low dye labeling did not drastically change the relative sites of
virus distribution. However, the high labeling did change tissue
distribution primarily by reducing viral genome content in the liver.
Discussion
This work was initiated to monitor the immediate and realtime
biodistribution of viruses in the seconds and minutes after i.v.
injection, when reporter gene tracking is not feasible. We chose
fluorophore labeling of virions as an approach that would be simple
to apply in the laboratory and to avoid generating radioactive
animals. Fluorescence imaging also hasthe advantage of more rapid
image capture (milliseconds) than radioactive imaging methods.
While this provides rapid kinetic imaging, fluorescence imaging is
less effective at deep tissue imaging than SPECT or PET imaging,
which have the added advantage of producing three-dimensional
information [9,10]. NIR fluorescence was used rather than
fluorescence in the visible range, since wavelength in the 800 nm
range have the lowest tissue absorbance and autofluorescence for
Figure 4. Enlargements of selected images from Figure 3 and Supplemental Movie S3, showing times and specific tissues that have
high levels of infrared signal. i= intestine; j= jugular; h= heart; v= blood vessel; L= liver.
doi:10.1371/journal.pone.0017076.g004
Figure 5. Quantitation of NIR fluorescence from liver and muscle for mice injected with dye alone or labeled viruses. Quantitation of
NIR fluorescence from liver and muscle at early time points for a single mouse that was injected with dye alone or the indicated labeled virus. A. Early
time points B. Later time points.
doi:10.1371/journal.pone.0017076.g005
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the green range (530 nm) or red range (710 nm) [11]. While NIR is
optimal, there is still some autofluorescence from the digestive tract
of mice due to chlorophyll autofluorescence. The use of low
autofluorescent chow can reduce, but not ablate this background to
improve signal to noise ratios.
Two concentrations of IR800 dye per virion were used in this
study: 100,000 dye molecules/virion and 10,000 dye molecules/
virion. Labeling at lower ratios produced virus preparations that
were below the sensitivity of detection by the current Lumazone
NIR imaging system. When compared to standards of known dye
concentrations, the 10,000 and 100,000 dye molecules per virion
labeling conditions produced virions with fluorescence equivalent
60 and 600 IR800 molecules per virion. This does not mean there
are these few fluorophores per virion, but is the fluorescence
equivalent. In practical terms, these ratios are the highest that can
be achieved to yield the most fluorescent viruses for detection with
the current imaging system.
The low-dye labeled Ad-GL injected mice had weak signal, but
the observed fluorescence was distinctly different from the dye
alone. In these mice, signal traveled through the catheter and into
the heart and thyroid regions of the animal. Over time, signal
began to pool in the liver, this is concurrent with the known uptake
of virus by Kupffer cells and blood factor mediated binding to
hepatocytes [3,12,13,14]. High-dye labeled Ad-GL followed the
same kinetics but with higher signal intensity. These data are
consistent with observations that more than 90% of Ad5 is being
sequestered by the liver following i.v. injection.
The high labeling condition provided the most striking imaging
quality particularly for kinetic tracking. Unfortunately, this level of
Figure 6. In vivo bioactivity and biodistribution of unlabeled and IR800-labed Ad-GL. Groups of 5 mice were injected by tail vein with
unlabeled or low or high-dose labeled Ad-GL. 24 hours later, the mice were imaged for luciferase activity (A and B) and select organs were analyzed
by qPCR for Ad genomes (C and D).
doi:10.1371/journal.pone.0017076.g006
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qPCR of viral genomes. In contrast, the low labeling condition had
modest effects on virus activity in the liver and only small effects on
viral genomes in the tested organs which did not appear to have
perturbedrelativedistribution. Given this, we anticipate that theuse
of NIR dyes with higher quantum yield and more sensitive imaging
systems will allow labeling at the low dye and lower dye to virion
ratio to enable imaging kinetics similar that observed for the high
dye samples, but without perturbing function.
In summary, this is the first report of the real-time dynamic
imaging at millisecond time scales of an intravenous infection by a
virus. This technique should be valuable in monitoring viruses,
viral and non-viral vectors, and nanoparticle distribution and
pharmacokinetics in a qualitative and quantitative fashion. This
proof of principle provides support for developing brighter
fluorophores or more sensitive imaging systems to enable lower
dye to virion ratios to be used.
Supporting Information
Movie S1 NIR imaging of IR800 free dye. This movie
corresponds to the still images of Figure 1.
(MOV)
Movie S2 NIR imaging of Ad labeled with low IR800.
This movie corresponds to the still images of Figure 2.
(MOV)
Movie S3 NIR imaging of Ad labeled with high IR800.
This movie corresponds to the still images of Figure 3.
(MOV)
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